Technology for vascular health
Detect cardiovascular diseases years in advance – when they are still preventable!
Microcirculation is life
More than 80% of cardiovascular diseases can be prevented if the risk factors are identified and eliminated in time.
But most people don’t know their own cardiovascular risk.
Cardiovascular diseases are the most common cause of death worldwide
The microcirculation is the functionally crucial endpoint of the cardiovascular system
Despite the importance of the microcirculation to human health, accurate noninvasive measurements have not been possible in the past.
We offer new perspectives for diagnostic care.
26% Macrocirculation
74% Microcirculation
Detect cardiovascular disease years in advance when it is still treatable!
Functional vascular changes can be detected using risk markers – long before the first morphological damage becomes apparent.
With our Retinal Vessel Analysis technology, we set the gold standard and are highly recognized in the scientific community.
Our product areas
Our algorithms for Static Vessel Analysis allow non-invasive and non-contact examination of the morphology of retinal vessels. This is associated with overall vascular health and the global state of the microcirculation and is thus an integral part of modern cardiovascular diagnostics.
Our Dynamic Vessel Analysis is a worldwide unique method for the non-invasive investigation of the function and autoregulation of retinal vessels using video sequences. In this process, the vessel calibers along the vessels are recorded and analyzed on the retina in a time-varying manner .
With the RCrodent systems, Imedos offers the only commercially available solution for non-contact imaging and fluorescein angiography for the smallest eyes. We thus give you the tools for easy static and dynamic examination of the microcirculation even on the animal model.
With the IOPstim system, Imedos is the only provider to enable the patient to increase the intraocular pressure easily and painlessly as a prerequisite for a gentle measurement of the retinal venous pressure for improved diagnosis of eye diseases such as glaucoma.
Cardiology
In addition to the important and efficient assessment of your patients' cardiovascular risk, Retinal Vessel Analysis methods are also suitable for various applications in routine clinical practice. For example, there is a discrepancy between standardized risk scores and the incidence of coronary artery disease in women.
Ophthalmology
Often, disturbed blood flow to the eye is the cause of the onset or progression of many eye diseases. Imedos' advanced Retinal Vessel Analysis technology makes it possible to diagnose these vascular components at an early stage and subsequently verify the impact of therapy.
Neurology
Pathologies of the microcirculation are associated with diverse clinical pictures in neurology. Therefore, the parameters of Retinal Vessel Analysis are suitable to draw conclusions about the risk of stroke, the severity of cerebral vascular diseases or other neurological diseases such as Alzheimer's disease.
Cardiometabolic prevention
The goal of cardiometabolic prevention is to prevent or delay the development and manifestation of vascular diseases at an early stage. The parameters of Retinal Vessel Analysis offer new possibilities to extend the established gold standards of macrovascular diagnostics by microcirculation.
Nephrology
Recent studies present the associations between retinal vascular changes, arterial hypertension, and renal changes. One example is results demonstrating the associations between venous dysregulation and end-state mortality in patients with chronic renal failure. In these studies, our Dynamic Vessel Analysis represents a novel diagnostic tool for risk stratification.
Hypertensiology
Around 1.3 billion people worldwide suffer from hypertension. However, since this disease is usually asymptomatic at the beginning, a good half of these patients are unaware of their disease and the associated risk. The microvessels of the retina are very sensitive to changes in blood pressure and thus often provide the first clues to development or pre-existing disease.
Our users
News
Microcirculation in microgravity
Imedos is currently on another exciting mission: together with scientists from the University of Düsseldorf, we are once again investigating the behavior of the microvessels of th
Off to bed and keep your eyes peeled for space medicine
Imedos technology for retinal vessel analysis is part of the latest bed rest study of NASA and DLR. During space missions, astronauts regularly experience extreme situations that a
The eye tells more than a thousand words
Preventing strokes by looking in the eye? This sounds futuristic, and yet something similar is already possible today. Our retinal vessel analysis devices allow the examination of
Current study: Does the functional analysis of retinal vessels allow statements on the progression of COVID-19?
The University Hospital Jena (UKJ) and the Jena-based manufacturer of medical devices Imedos Systems GmbH have joint forces to determine whether the functional analysis of vessels
Retinal vessel analysis and obesity
Retinal Vessel Analysis and Obesity: static vessel analysis delivers innovative method to assess therapeutic success in obese patients Almost a quarter of all adults in Germany suf
Hypertension in childhood
Specialist article provides new insights: Development of high blood pressure can be detected as early as in childhood According to a new study from Switzerland using the method of
Targeted identification of high-risk individuals for severe progressions of COVID-19
Imedos Static Vessel Analysis: eye scan enables targeted identification of individuals at risk for severe COVID-19 progression Despite initial easing of lockdowns and restrictions
Imedos takes off: Vascular analysis in weightlessness
Astronauts and jet pilots regularly put themselves in extreme situations that can affect your health and trigger ailments. Das German Aerospace Center (DLR) is constant
Shooting date with MDR Thuringia
At the end of last year, we received an interesting inquiry from Mitteldeutscher Rundfunk (MDR): The editors were interested in our technology of retinal vessel analysis. They woul
